Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation. - Mollenhauer,B.; Bibl,M.; Esselmann,H. (J Neurol Neurosurg Psychiatry, 2006)